Company registration number 08220446 (England and Wales)
DAVIS SCIENTIFIC TREATMENTS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2023
PAGES FOR FILING WITH REGISTRAR
DAVIS SCIENTIFIC TREATMENTS LIMITED
CONTENTS
Page
Accountants' report
1
Balance sheet and notes to the financial statements
2 - 3
DAVIS SCIENTIFIC TREATMENTS LIMITED
ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF DAVIS SCIENTIFIC TREATMENTS LIMITED FOR THE YEAR ENDED 30 SEPTEMBER 2023
- 1 -

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Davis Scientific Treatments Limited for the year ended 30 September 2023, which comprise the balance sheet, from the company’s accounting records and from information and explanations you have given us.

 

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com/regulation.

This report is made solely to the board of directors of Davis Scientific Treatments Limited, as a body, in accordance with the terms of our engagement letter dated 8 December 2014. Our work has been undertaken solely to prepare for your approval the financial statements of Davis Scientific Treatments Limited and state those matters that we have agreed to state to the board of directors of Davis Scientific Treatments Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Davis Scientific Treatments Limited and its board of directors as a body, for our work or for this report.

It is your duty to ensure that Davis Scientific Treatments Limited has kept adequate accounting records and to prepare statutory financial statements that comply with the requirements of the Companies Act 2006. You consider that Davis Scientific Treatments Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Davis Scientific Treatments Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Paish Tooth Limited
17 April 2024
Chartered Accountants
4th Floor
Llanthony Warehouse
The Docks
Gloucester
Gloucestershire
GL1 2EH
DAVIS SCIENTIFIC TREATMENTS LIMITED
BALANCE SHEET
AS AT
30 SEPTEMBER 2023
30 September 2023
- 2 -
2023
2022
£
£
£
£
Fixed assets
92,078
64,408
Current assets
219,540
232,018
Prepayments and accrued income
10,491
6,679
Creditors: amounts falling due within one year
(80,046)
(90,987)
Net current assets
149,985
147,710
Total assets less current liabilities
242,063
212,118
Creditors: amounts falling due after more than one year
(31,454)
(37,463)
Accruals and deferred income
(7,600)
(10,512)
Net assets
203,009
164,143
Capital and reserves
203,009
164,143
Notes to the financial statements
1
Employees

The average number of persons, including directors, employed by the company during the year was as follows:

2023
2022
Number
Number
Employees
5
5

Davis Scientific Treatments Limited is a private company limited by shares incorporated in England and Wales. The registered office is Unit 5D, Delta Drive,, Tewkesbury Industrial Estate, Ashchurch, Tewkesbury, Gloucestershire, GL20 8HB.

For the year ended 30 September 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime' and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

DAVIS SCIENTIFIC TREATMENTS LIMITED
BALANCE SHEET (CONTINUED)
AS AT
30 SEPTEMBER 2023
30 September 2023
- 3 -
The financial statements were approved by the board of directors and authorised for issue on 17 April 2024 and are signed on its behalf by:
R D R Andrews
Director
Company Registration Number 08220446
2023-09-302022-10-01falseCCH SoftwareCCH Accounts Production 2024.100No description of principal activityR D R AndrewsM C AndrewsG L FrancisP J FrancisA WilliamsonN J Williamsonfalsefalse082204462022-10-012023-09-30082204462023-09-30082204462022-09-3008220446core:CurrentFinancialInstrumentscore:WithinOneYear2023-09-3008220446core:CurrentFinancialInstrumentscore:WithinOneYear2022-09-3008220446core:Non-currentFinancialInstruments2023-09-3008220446core:Non-currentFinancialInstruments2022-09-30082204462021-10-012022-09-3008220446bus:Director12022-10-012023-09-3008220446bus:PrivateLimitedCompanyLtd2022-10-012023-09-3008220446bus:SmallCompaniesRegimeForAccounts2022-10-012023-09-3008220446bus:Micro-entities2022-10-012023-09-3008220446bus:AuditExemptWithAccountantsReport2022-10-012023-09-3008220446bus:Director22022-10-012023-09-3008220446bus:Director32022-10-012023-09-3008220446bus:Director42022-10-012023-09-3008220446bus:Director52022-10-012023-09-3008220446bus:Director62022-10-012023-09-3008220446bus:FullAccounts2022-10-012023-09-30xbrli:purexbrli:sharesiso4217:GBP